BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31033834)

  • 1. Cryopreservation and Transplantation of Vascularized Composite Transplants: Unique Challenges and Opportunities.
    Shani N; Friedman O; Arav A; Natan Y; Gur E
    Plast Reconstr Surg; 2019 May; 143(5):1074e-1080e. PubMed ID: 31033834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward Development of the Delayed Tolerance Induction Protocol for Vascularized Composite Allografts in Nonhuman Primates.
    Lellouch AG; Ng ZY; Rosales IA; Schol IM; Leonard DA; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
    Plast Reconstr Surg; 2020 Apr; 145(4):757e-768e. PubMed ID: 32221215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat Hindlimb Cryopreservation and Transplantation: A Step Toward "Organ Banking".
    Arav A; Friedman O; Natan Y; Gur E; Shani N
    Am J Transplant; 2017 Nov; 17(11):2820-2828. PubMed ID: 28422434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascularized composite allograft-specific characteristics of immune responses.
    Issa F
    Transpl Int; 2016 Jun; 29(6):672-81. PubMed ID: 26927941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascularized Composite Allotransplantation: A Functional Hind Limb Model in Mice.
    Vernon R; Wang J; Song M; Wilson N; Moris D; Cendales L
    J Surg Res; 2020 Jun; 250():119-124. PubMed ID: 32044508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.
    Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC
    Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in machine perfusion, organ preservation, and cryobiology: potential impact on vascularized composite allotransplantation.
    Burlage LC; Tessier SN; Etra JW; Uygun K; Brandacher G
    Curr Opin Organ Transplant; 2018 Oct; 23(5):561-567. PubMed ID: 30080697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Urogenital Epithelium and Corporal Tissues Are the Primary Targets of Rejection in Penile Vascularized Composite Allotransplantation: A New Real-Time Tissue-Based Monitoring System.
    Lough DM; Sopko NA; Matsui H; Miller D; Swanson EW; Bluebond-Langner R; Brandacher G; Burnett AL; Bivalacqua TJ; Redett RJ
    Plast Reconstr Surg; 2019 Mar; 143(3):534e-544e. PubMed ID: 30817651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation.
    Wang HD; Fidder SAJ; Miller DT; Furtmüller GJ; Ahmadi AR; Nägele F; Lopez J; Quan A; Budihardjo J; Lough DM; Akpinarli B; Etra JW; Vasilic D; Raimondi G; Lee WPA; Montgomery RA; Sun Z; Brandacher G
    Transplantation; 2018 Apr; 102(4):593-600. PubMed ID: 29298238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation.
    Radu CA; Fischer S; Diehm Y; Hetzel O; Neubrech F; Dittmar L; Kleist C; Gebhard MM; Terness P; Kneser U; Kiefer J
    Langenbecks Arch Surg; 2018 Feb; 403(1):83-92. PubMed ID: 28823033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.
    Kueckelhaus M; Fischer S; Seyda M; Bueno EM; Aycart MA; Alhefzi M; ElKhal A; Pomahac B; Tullius SG
    Transpl Int; 2016 Jun; 29(6):655-62. PubMed ID: 26265179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Static Cold Storage on Skeletal Muscle after Vascularized Composite Tissue Allotransplantation.
    Gok E; Kubiak CA; Guy E; Kemp SWP; Ozer K
    J Reconstr Microsurg; 2020 Jan; 36(1):9-15. PubMed ID: 31302903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Influence of Timing and Frequency of Adipose-Derived Mesenchymal Stem Cell Therapy on Immunomodulation Outcomes After Vascularized Composite Allotransplantation.
    Plock JA; Schnider JT; Schweizer R; Zhang W; Tsuji W; Waldner M; Solari MG; Marra KG; Rubin JP; Gorantla VS
    Transplantation; 2017 Jan; 101(1):e1-e11. PubMed ID: 27893612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological and inflammatory mapping of vascularized composite allograft rejection processes in a rat model.
    Friedman O; Carmel N; Sela M; Abu Jabal A; Inbal A; Ben Hamou M; Krelin Y; Gur E; Shani N
    PLoS One; 2017; 12(7):e0181507. PubMed ID: 28746417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose-derived cellular therapies in solid organ and vascularized-composite allotransplantation.
    Stivers KB; Beare JE; Chilton PM; Williams SK; Kaufman CL; Hoying JB
    Curr Opin Organ Transplant; 2017 Oct; 22(5):490-498. PubMed ID: 28873074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-graft injection of tacrolimus promotes survival of vascularized composite allotransplantation.
    Olariu R; Denoyelle J; Leclère FM; Dzhonova DV; Gajanayake T; Banz Y; Hayoz M; Constantinescu M; Rieben R; Vögelin E; Taddeo A
    J Surg Res; 2017 Oct; 218():49-57. PubMed ID: 28985877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of oxidative damage markers in a rat model of vascularized composite allotransplantation.
    Hu CH; Lin CH; Chang NJ; Hu CW; Lin CH
    Plast Reconstr Surg; 2013 Oct; 132(4):530e-541e. PubMed ID: 24076700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Composite Graft Pretreatment With Hydrogen Sulfide Delays the Onset of Acute Rejection.
    Fries CA; Lawson SD; Wang LC; Spencer JR; Roth M; Rickard RF; Gorantla VS; Davis MR
    Ann Plast Surg; 2019 Apr; 82(4):452-458. PubMed ID: 30628928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine Perfusion Enables 24-h Preservation of Vascularized Composite Allografts in a Swine Model of Allotransplantation.
    Goutard M; Tawa P; Berkane Y; Andrews AR; Pendexter CA; de Vries RJ; Pozzo V; Romano G; Lancia HH; Filz von Reiterdank I; Bertheuil N; Rosales IA; How IDAL; Randolph MA; Lellouch AG; Cetrulo CL; Uygun K
    Transpl Int; 2024; 37():12338. PubMed ID: 38813393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker and surrogate development in vascularised composite allograft transplantation: Current progress and future challenges.
    Honeyman C; Stark H; Wang HC; Hester J; Issa F; Giele H
    J Plast Reconstr Aesthet Surg; 2021 Apr; 74(4):711-717. PubMed ID: 33436335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.